Home / News / Almac Team Up with Irish Ameri…

Almac Team Up with Irish American Business Chamber & Network for Life Sciences Forum

POSTED ON 17th November 2016 by Arran Chemical Company

Panellists for the event include Brendan Fenton, Regional Finance Director for Australia, Canada and Western Europe for Bristol-Myers Squibb, John Barry, Head of Portfolio Sourcing and Relationship Management, Merck Research Laboratories at Merck & Co., and Michael Sapienza, Chief Executive Officer of The Colon Cancer Alliance. The panel will be moderated by George Tiger, Vice President Global Business Development, Almac Clinical Technologies. The discussion will span dynamic industry topics including the greatest challenges faced today and the next generation of future collaborations that will be needed, the impact of the pharmaceutical industry in the broader economy, the pharmaceutical business model and risk profile and patient advocacy and engagement.

George commented: “We are delighted to be working with the British American Business Council and the Irish American Business Chamber and Network of Philadelphia on this initiative.  It is a fantastic opportunity to share knowledge and discuss the pertinent topics relating to our industry – in addition to sharing a platform with experts and key opinion leaders from across the pharmaceutical spectrum.” 

The Irish American Business Chamber & Network, Inc. (IABCN) is a nonpartisan business organisation promoting the interests of its members and the development of economic and educational relationships between the United States and the Isle of Ireland.

For more information, visit iabcn.org or email abarry@iabcn.org.

About Almac Group
‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to over 600 companies globally within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organization that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel.  Almac is headquartered in Craigavon, Northern Ireland with operations in Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).

For more information visit – www.almacgroup.com or e-mail media@almacgroup.com.


By using this website, you agree to the use of cookies as described in our Privacy Policy